Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
45.1M
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
500K
-
Shares change
-
-38M
-
Total reported value, excl. options
-
$1.19M
-
Value change
-
-$208M
-
Number of buys
-
5
-
Number of sells
-
-93
-
Price
-
$5.38
Significant Holders of THIRD HARMONIC BIO, INC. - Common Stock, par value $0.0001 per share (THRD) as of Q3 2025
109 filings reported holding THRD - THIRD HARMONIC BIO, INC. - Common Stock, par value $0.0001 per share as of Q3 2025.
THIRD HARMONIC BIO, INC. - Common Stock, par value $0.0001 per share (THRD) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 500K shares
of 45.1M outstanding shares and own 1.11% of the company stock.
Largest 10 shareholders include JBF Capital, Inc. (250K shares), DIMENSIONAL FUND ADVISORS LP (93.9K shares), CANTOR FITZGERALD, L. P. (86.3K shares), Nuveen, LLC (28K shares), RHUMBLINE ADVISERS (20.7K shares), MetLife Investment Management, LLC (16.9K shares), Ameritas Investment Partners, Inc. (2.02K shares), Russell Investments Group, Ltd. (803 shares), AMALGAMATED BANK (665 shares), and GAMMA Investing LLC (458 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.